| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 7,514 | 14,280 | ||
| Prepaid expenses and other current assets | 590 | 823 | ||
| Total current assets | 8,104 | 15,103 | ||
| Property and equipment | 2,203 | - | ||
| Less accumulated depreciation | 1,522 | - | ||
| Property and equipment-net | 681 | 748 | ||
| Operating lease right-of-use assets | 7,825 | 8,104 | ||
| Other noncurrent assets | 519 | 529 | ||
| Total assets | 17,129 | 24,484 | ||
| Accounts payable | 922 | 4,716 | ||
| Accrued expenses | 1,353 | 1,221 | ||
| Current loan payable (net of discount and issuance costs of nil and 74, respectively) | 0 | 0 | ||
| Current operating lease liabilities | 1,147 | 1,103 | ||
| Accrued compensation | 103 | 101 | ||
| Interest payable | 0 | 0 | ||
| Total current liabilities | 3,525 | 7,141 | ||
| Operating lease liabilities, less current portion | 7,258 | 7,560 | ||
| Total liabilities | 10,783 | 14,701 | ||
| Common stock, 0.001 par value 100,000,000 shares authorized 4,440,161 and 3,382,432 shares issued and outstanding at september 30, 2025 and december 31, 2024, respectively | 4 | 4 | ||
| Additional paid-in capital | 235,689 | 235,615 | ||
| Accumulated deficit | -229,347 | -225,836 | ||
| Total stockholders equity | 6,346 | 9,783 | ||
| Total liabilities and stockholders equity | 17,129 | 24,484 | ||
Tempest Therapeutics, Inc. (TPST)
Tempest Therapeutics, Inc. (TPST)